{"id":"https://openalex.org/W1576582769","doi":null,"title":"Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.","display_name":"Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.","publication_year":2002,"publication_date":"2002-04-01","ids":{"openalex":"https://openalex.org/W1576582769","mag":"1576582769","pmid":"https://pubmed.ncbi.nlm.nih.gov/11929821"},"language":"en","primary_location":{"id":"pmid:11929821","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11929821","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058101713","display_name":"Chris Waskewich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chris Waskewich","raw_affiliation_strings":["Garden State Cancer Center, Belleville, New Jersey 07109, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Garden State Cancer Center, Belleville, New Jersey 07109, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110227609","display_name":"Rosalyn D. Blumenthal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosalyn D Blumenthal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083351139","display_name":"Honglan Li","orcid":"https://orcid.org/0000-0001-8919-2894","observed_orcids":["https://orcid.org/0000-0001-8919-2894"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Honglan Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091087285","display_name":"Rhona Stein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rhona Stein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003890903","display_name":"David M. Goldenberg","orcid":"https://orcid.org/0000-0001-5539-421X","observed_orcids":["https://orcid.org/0000-0001-5539-421X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David M Goldenberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Jack Burton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jack Burton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":14.7373,"has_fulltext":false,"cited_by_count":202,"citation_normalized_percentile":{"value":0.9941566,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"62","issue":"7","first_page":"2029","last_page":"33"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11319","display_name":"Curcumin's Biomedical Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.984000027179718},{"id":"https://openalex.org/keywords/rofecoxib","display_name":"rofecoxib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.949999988079071},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.906000018119812},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7799999713897705},{"id":"https://openalex.org/keywords/ic50","display_name":"IC50","score":0.6639999747276306},{"id":"https://openalex.org/keywords/cox-2-expression","display_name":"COX-2 expression","score":0.6729999780654907},{"id":"https://openalex.org/keywords/anticancer-drug-screening","display_name":"anticancer drug screening","score":0.574999988079071}],"concepts":[{"id":"https://openalex.org/C2778582115","wikidata":"https://www.wikidata.org/wiki/Q411412","display_name":"Rofecoxib","level":4,"score":0.9097181558609009},{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.9059919118881226},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5694853663444519},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.5546035766601562},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5420843362808228},{"id":"https://openalex.org/C2777031258","wikidata":"https://www.wikidata.org/wiki/Q377458","display_name":"COX-2 inhibitor","level":4,"score":0.529074490070343},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5260745882987976},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.4844701290130615},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48002782464027405},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46959272027015686},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43232011795043945},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4163963496685028},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.357954740524292},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30779290199279785},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2682744562625885},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.19463524222373962},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12574127316474915},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.060702890157699585}],"mesh":[{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004847","descriptor_name":"Epithelial Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004847","descriptor_name":"Epithelial Cells","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D004847","descriptor_name":"Epithelial Cells","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006131","descriptor_name":"Growth Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011451","descriptor_name":"Prostaglandin-Endoperoxide Synthases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11929821","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11929821","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:1576582769","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11929821","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4330179423","display_name":"RADIOIMMUNODETECTION AND RADIOIMMUNOTHERAPY OF CANCER","funder_award_id":"R35CA039841","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1514928695","https://openalex.org/W1977904573","https://openalex.org/W1979201752","https://openalex.org/W2026307857","https://openalex.org/W2031694725","https://openalex.org/W2042042913","https://openalex.org/W2048925802","https://openalex.org/W2050352100","https://openalex.org/W2051279880","https://openalex.org/W2055951936","https://openalex.org/W2064332031","https://openalex.org/W2068806248","https://openalex.org/W2087744847","https://openalex.org/W2088404163","https://openalex.org/W2108460768","https://openalex.org/W2113745276","https://openalex.org/W2127558096","https://openalex.org/W2140873821","https://openalex.org/W2143296984","https://openalex.org/W2148122132","https://openalex.org/W2148907720","https://openalex.org/W2150966393","https://openalex.org/W2156470937","https://openalex.org/W2156881931","https://openalex.org/W2171518012","https://openalex.org/W2336169581"],"related_works":["https://openalex.org/W2127560071","https://openalex.org/W1997659114","https://openalex.org/W1991307214","https://openalex.org/W2120228063","https://openalex.org/W2216690849","https://openalex.org/W2181536337","https://openalex.org/W2361206304","https://openalex.org/W2019243373","https://openalex.org/W2388971191","https://openalex.org/W2394860688"],"abstract_inverted_index":{"Cyclooxygenase-2":[0],"(COX-2)":[1],"is":[2],"an":[3,35],"important":[4,120,226],"cellular":[5],"target":[6],"for":[7,41,74,109,154,175],"both":[8,75,129],"therapy":[9],"and/or":[10],"prevention":[11],"of":[12,19,34,37,45,64,70,128,170,181,192,202,235,248,254],"inflammatory":[13,155],"disorders":[14],"and":[15,28,47,53,77,94,133,146,151,208,237],"cancer.":[16],"The":[17,32],"advent":[18],"selective":[20],"COX-2":[21,89,97,134,142,259],"inhibitors":[22],"now":[23],"allows":[24],"a":[25,245],"more":[26],"precise":[27],"safer":[29],"treatment":[30,213],"approach.":[31],"screening":[33],"array":[36],"cancer":[38,79,166,239],"cell":[39,80,84,131,167,182,197,210,240],"lines":[40,85,103,211],"growth":[42],"inhibitory":[43],"effects":[44,63,122,164,253],"COX-2-selective":[46],"-nonselective":[48],"inhibitors,":[49],"including":[50],"celecoxib":[51,65,110,145,176],"(Celebrex)":[52],"rofecoxib":[54,221],"(Vioxx),":[55],"produced":[56],"two":[57,256],"unanticipated":[58],"findings.":[59],"Firstly,":[60],"the":[61,130,188,231,249,255],"antiproliferative":[62,121,163],"were":[66,104,112,123,126,173,204],"noted":[67],"to":[68,106,115],"be":[69],"very":[71,113],"similar":[72,114,149,200],"magnitude":[73],"hematopoietic":[76,83,238],"epithelial":[78,102,236],"lines.":[81,168,183],"Most":[82],"had":[86],"no":[87,185],"detectable":[88],"expression":[90],"by":[91],"reverse":[92],"transcription-PCR,":[93],"none":[95],"expressed":[96],"protein.":[98],"In":[99],"addition,":[100],"COX-2-negative":[101],"found":[105],"have":[107],"IC50s":[108,169],"that":[111,125,141,228],"their":[116,160],"COX-2+":[117,207],"counterparts.":[118],"Thus,":[119],"observed":[124,140,174,205],"independent":[127],"lineage":[132],"status.":[135],"Secondly,":[136],"it":[137],"was":[138,194],"also":[139],"inhibitor":[143],"drugs,":[144],"rofecoxib,":[147],"with":[148,214,216],"COX-2-selectivity":[150],"clinical":[152],"efficacy":[153],"indications,":[156],"differed":[157],"significantly":[158],"in":[159,161,187,206,227,250],"vitro":[162,251],"on":[165],"35-65":[171],"microM":[172],"across":[177],"this":[178],"entire":[179],"panel":[180],"Finally,":[184],"difference":[186],"mode":[189],"or":[190],"degree":[191],"cytotoxicity":[193],"apparent":[195],"between":[196],"lines,":[198,241],"because":[199],"levels":[201,219],"apoptosis":[203],"-negative":[209],"after":[212,220],"celecoxib,":[215],"correspondingly":[217],"lower":[218],"treatment.":[222],"These":[223],"data":[224],"are":[225],"they":[229],"provide":[230],"first":[232],"direct":[233,246],"comparison":[234,247],"as":[242,244],"well":[243],"anticancer":[252],"clinically":[257],"available":[258],"inhibitors.":[260]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}